DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril

Gynækologisk/obstetrisk afd., Kolding

Boehringer Ingelheim Investigational Site, Riihimäki

Boehringer Ingelheim Investigational Site, Tampere

Apopleksiafsnittet, Frederiksberg

Boehringer Ingelheim Investigational Site, Frederiksberg C

Lungemedicinsk Forskning, Hellerup

Medical Dept. B0642, Hillerød

Hvidovre Hospital, Hvidovre

Boehringer Ingelheim Investigational Site, Hyvinkää

Boehringer Ingelheim Investigational Site, Jyväskylä

Kuopion yliopistollinen sairaala, Keuhkoklinikka, Kuopio

Bosch Medicentrum, 's-Hertogenbosch

Dept. of Internal Medicine, Utrecht

Boehringer Ingelheim Investigational Site, Arendal

Boehringer Ingelheim Investigational Site, Jessheim

Boehringer Ingelheim Investigational Site, Skogn

Hjertelaget Research Foundation, Stavanger

Medicinkliniken, Eksjö

Medicinkliniken, Helsingborg

Boehringer Ingelheim Investigational Site, Helsingborg

Boehringer Ingelheim Investigational Site, Munkedal

Boehringer Ingelheim Investigational Site, Tranås

Boehringer Ingelheim Investigational Site, Uddevalla

Samariterhemmets sjukhus, Uppsala

Boehringer Ingelheim Investigational Site, Vetlanda

Boehringer Ingelheim Investigational Site, Atherstone

Boehringer Ingelheim Investigational Site, Barry

Dept. of Diabetes, Birmingham

Department of Respiratory Medicine, Birmingham

Royal Bournemouth Hospital, Bournemouth

Finance Office (Research Unit), Newcastle upon Tyne

Northampton General Hospital, Northampton

Boehringer Ingelheim Investigational Site, Northampton

Diabetes Centre,, Nuneaton

Lucille Packard Children's Health Services at Stanford, Palo Alto

Boehringer Ingelheim Investigational Site, Pont-y-clun

Diabetes Centre, Rugby